Last quarter (Q3 2023), Love Pharma Inc's total revenue was C$―, a decrease of ― from the same quarter last year. In Q3, Love Pharma Inc's net income was C$-28.37K. See Love Pharma Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Sep 20	Sep 19	Sep 18
Total Revenue	-	-	-	C$ 0.00	C$ 0.00	C$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	C$ 0.00
Operating Expense	C$ 189.34K	C$ 1.66M	C$ 8.24M	C$ 128.30K	C$ 329.88K	C$ 114.39K
Operating Income	C$ -749.44K	C$ -1.66M	C$ -8.24M	C$ -128.30K	C$ -329.88K	C$ -114.39K
Net Non Operating Interest Income Expense	C$ -15.70K	C$ -19.14K	C$ 10.28K	-	-	C$ 0.00
Other Income Expense	C$ 2.80K	C$ -2.00K	C$ -1.27M	-	-	C$ -272.37K
Pretax Income	C$ -2.63M	C$ -3.58M	C$ -9.52M	C$ -128.30K	C$ -329.88K	C$ -114.39K
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ -2.63M	C$ -3.58M	C$ -9.52M	C$ -128.30K	C$ -329.88K	C$ 1.97M
Basic EPS	C$ -0.10	C$ -0.09	C$ -0.04	C$ >-0.01	C$ >-0.01	C$ 0.01
Diluted EPS	C$ -0.10	C$ -0.09	C$ -0.04	C$ >-0.01	C$ >-0.01	C$ 0.01
Basic Average Shares	C$ 152.83M	C$ 41.33M	C$ 214.52M	C$ 90.64M	C$ 136.79M	C$ 130.42M
Diluted Average Shares	C$ 152.83M	C$ 41.33M	C$ 214.52M	C$ 90.64M	C$ 136.79M	C$ 130.42M
Dividend Per Share	-	-	-	C$ 0.00	C$ 0.00	C$ 0.01
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 189.34K	C$ 1.66M	C$ -8.24M	C$ 128.30K	C$ 329.88K	C$ 114.39K
Net Income From Continuing And Discontinued Operation	C$ -2.63M	C$ -3.58M	C$ -9.52M	C$ -128.30K	C$ -329.88K	C$ 1.97M
Normalized Income	C$ -2.50M	C$ -701.67K	C$ -9.52M	C$ -128.30K	C$ -329.88K	C$ -114.39K
Interest Expense	-	-	-	-	-	C$ 0.00
EBIT	C$ -2.61M	C$ -3.56M	C$ -9.53M	C$ -128.30K	C$ -329.88K	C$ -114.39K
EBITDA	C$ -450.69K	C$ -3.56M	-	C$ -128.30K	C$ -329.88K	C$ -114.39K

Currency in CAD

Love Pharma Inc Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing